<DOC>
	<DOCNO>NCT01935622</DOCNO>
	<brief_summary>Non-ischemic cardiomyopathy heart failure highly influenced presence systemic inflammation . Doxycycline FDA-approved drug treat bacterial infection also show powerful anti-inflammatory effect . In study plan determine effect Doxycycline patient stable heart failure non-ischemic cardiomyopathy peak aerobic exercise capacity ( peak V02 ) ventilator efficiency measure cardiopulmonary test .</brief_summary>
	<brief_title>Safety Efficacy Doxycycline Patients With Non-Ischemic Cardiomyopathy</brief_title>
	<detailed_description>In study Safety Efficacy Doxycycline Patients Non-Ischemic Cardiomyopathy Population , enroll 24 patient clinical diagnosis heart failure non-ischemic cardiomyopathy ( recent imaging study document LV ejection fraction &lt; 50 % , history coronary ischemic heart disease ) single-center , randomize , double-blinded , placebo-controlled clinical trial allocation 1:1:1 Doxycycline 100 mg twice daily Doxycycline 20 mg twice daily Placebo 2 week .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Heart Failure , Systolic</mesh_term>
	<mesh_term>Doxycycline</mesh_term>
	<criteria>Nonischemic cardiomyopathy ( LVEF &lt; 40 % ) Heart failure NYHA IIIII Age &lt; 18 Recent change ( previous 3 month ) HF maintenance medication ( betablockers , angiotensin convert enzyme [ ACE ] inhibitor , aldosterone antagonist , vasodilator , cardiac glycoside , diuretic ) Hospitalization worsen HF acute decompensated HF within previous 12 month History coronary ischemic heart disease Anticipated need cardiac resynchronization therapy ( CRT ) automatedimplantable cardioverter defibrillator ( AICD ) coronary revascularization cardiac surgery Angina electrocardiograph ( ECG ) change limit maximum exertion cardiopulmonary exercise test Active infection include chronic infection Active cancer ( prior diagnosis cancer within past 10 year ) Recent ( &lt; 14 day ) use antiinflammatory drug ( include NSAIDs ) , Chronic inflammatory disorder ( include limit rheumatoid arthritis , systemic lupus erythematosus ) , malignancy , comorbidity limit survival ability complete study Pregnancy Inability give inform consent Other condition limit completion cardiopulmonary exercise test completion study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>heart failure</keyword>
	<keyword>non-ischemic cardiomyopathy</keyword>
</DOC>